Bio-Path Holdings Correlations

BPTH
 Stock
  

USD 3.06  0.12  3.77%   

The correlation of Bio-Path Holdings is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio-Path Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio-Path Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Continue to Trending Equities.
  
The ability to find closely correlated positions to Bio-Path Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio-Path Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio-Path Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio-Path Holdings to buy it.

Moving against Bio-Path Holdings

-0.59NSSNustar LogisticsPairCorr

Related Correlations

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

The Correlation Coefficient is a useful tool to identify correlated or non-correlated securities, which is essential in developing a diversified portfolio. It tells us the relationship between two positions you have in your portfolio or considering acquiring. Over a given time period, the two securities movetogether when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
  
High negative correlations   

Bio-Path Holdings Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Bio-Path Stock performing well and Bio-Path Holdings company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Bio-Path Holdings' multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
TWTR 1.64  0.18  0.06  0.19  2.79  0.07 (1.53)  4.00 (2.55)  15.22 
MSFT 1.40 (0.02)  0.00 (0.06)  0.00 (0.0179)  0.00  2.78 (3.17)  12.18 
UBER 2.88  0.52  0.15  0.36  2.75  0.13 (3.15)  5.60 (4.70)  25.11 
F 2.20  0.24  0.06  0.09  3.02  0.07 (2.37)  5.15 (3.71)  18.45 
T 0.97 (0.31)  0.00 (0.51)  0.00 (0.20)  0.00  1.62 (2.33)  9.44 
A 1.66  0.20  0.10  0.11  1.85  0.09 (1.86)  3.43 (3.13)  11.70 
CRM 2.13 (0.09)  0.00 (0.10)  0.00 (0.0457)  0.00  3.94 (4.55)  12.87 
JPM 1.29 (0.01)  0.00 (0.06)  0.00 (0.0099)  0.00  2.61 (2.88)  8.06 
MRK 0.98 (0.01)  0.00 (0.07)  0.00  0.0139  0.00  2.09 (2.13)  6.11 
XOM 1.79  0.02  0.02 (0.01)  2.21  0.0183 (1.84)  3.19 (3.70)  8.84 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bio-Path Holdings without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Pair Correlation Now

   

Pair Correlation

Compare performance and examine fundamental relationship between any two equity instruments
All  Next Launch Module

Bio-Path Holdings Corporate Directors

Bio-Path Holdings corporate directors refer to members of a Bio-Path Holdings board of directors. The board of directors generally takes responsibility for the Bio-Path Holdings' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Bio-Path Holdings' board members must vote for the resolution. The Bio-Path Holdings board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Paul Aubert - Independent DirectorProfile
Douglas Morris - Co-Founder and DirectorProfile
Mark Colonnese - Independent DirectorProfile
Amy Sing - Independent DirectorProfile

Invested in Bio-Path Holdings?

The danger of trading Bio-Path Holdings is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bio-Path Holdings is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bio-Path Holdings. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bio-Path Holdings is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. You can also try Shere Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for analysis

When running Bio-Path Holdings price analysis, check to measure Bio-Path Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio-Path Holdings is operating at the current time. Most of Bio-Path Holdings' value examination focuses on studying past and present price action to predict the probability of Bio-Path Holdings' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bio-Path Holdings' price. Additionally, you may evaluate how the addition of Bio-Path Holdings to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Is Bio-Path Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio-Path Holdings. If investors know Bio-Path will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio-Path Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bio-Path Holdings is measured differently than its book value, which is the value of Bio-Path that is recorded on the company's balance sheet. Investors also form their own opinion of Bio-Path Holdings' value that differs from its market value or its book value, called intrinsic value, which is Bio-Path Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio-Path Holdings' market value can be influenced by many factors that don't directly affect Bio-Path Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio-Path Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine Bio-Path Holdings value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio-Path Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.